IOBT
Income statement / Annual
Last year (2024), IO Biotech, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, IO Biotech, Inc.'s net income was -$95.49 M.
See IO Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$849.00 K
|
$756.00 K
|
$540.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$849.00 K
|
-$756.00 K
|
-$540.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$71.48 M
|
$67.83 M
|
$46.99 M
|
$30.15 M
|
$8.46 M
|
$7.94 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$11.08 M
|
$0.00
|
$1.98 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$22.84 M
|
$22.86 M
|
$23.90 M
|
$11.08 M
|
$1.68 M
|
$1.98 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$94.33 M
|
$90.69 M
|
$70.88 M
|
$41.23 M
|
$10.15 M
|
$9.91 M
|
| Cost And Expenses |
$95.18 M
|
$91.44 M
|
$71.42 M
|
$41.23 M
|
$10.15 M
|
$9.91 M
|
| Interest Income |
$4.72 M
|
$5.88 M
|
$1.41 M
|
$361.00
|
$26.00
|
$6.00
|
| Interest Expense |
$0.00
|
$0.00
|
$302.00 K
|
$361.00 K
|
$26.00 K
|
$6.00 K
|
| Depreciation & Amortization |
$849.00 K
|
$756.00 K
|
$540.00 K
|
$2.00 K
|
$0.00
|
$9.91 M
|
| EBITDA |
-$93.20 M |
-$84.48 M |
-$69.34 M |
-$67.45 M |
-$12.02 M |
-$824.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.13 M
|
$6.21 M
|
$1.24 M
|
-$26.58 M
|
-$1.90 M
|
-$830.00 K
|
| Income Before Tax |
-$94.05 M
|
-$85.23 M
|
-$70.19 M
|
-$67.81 M
|
-$12.04 M
|
-$10.74 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$1.44 M
|
$852.00 K
|
$1.27 M
|
$68.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$95.49 M
|
-$86.08 M
|
-$71.46 M
|
-$67.88 M
|
-$12.04 M
|
-$10.75 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.45 |
-1.98 |
-2.48 |
-2.36 |
-1.05 |
-60.73 |
| EPS Diluted |
-1.45 |
-1.98 |
-2.48 |
-2.36 |
-1.05 |
-60.66 |
| Weighted Average Shares Out |
$65.88 M
|
$43.54 M
|
$28.82 M
|
$28.82 M
|
$11.55 M
|
$177.00 K
|
| Weighted Average Shares Out Diluted |
$65.88 M
|
$43.54 M
|
$28.82 M
|
$28.82 M
|
$11.55 M
|
$177.20 K
|
| Link |
|
|
|
|
|
|
